Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

5.750 -0.300 (-4.96%)

Streaming Delayed Price Updated: 12:36 PM EDT, Aug 5, 2026 Add to My Watchlist

Price and Volume

Volume	114,615
Open	6.010
Bid (Size)	5.720 (800)
Ask (Size)	5.800 (400)
Prev. Close	6.050
Today's Range	5.660 - 6.228
52wk Range	4.510 - 69.00
Shares Outstanding	13,012,866
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Top movers in Tuesday's pre-market session ↗

July 14, 2026

Via Chartmill

Unusual volume stocks are being observed in Monday's session. ↗

July 06, 2026

Via Chartmill

Performance

YTD	-72.0%	-72.0%
1 Month	+2.5%	+2.5%
3 Month	-78.9%	-78.9%
6 Month	-79.8%	-79.8%
1 Year	-58.2%	-58.2%

More News

Which stocks are moving on Wednesday? ↗

July 01, 2026

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 01, 2026

Via Benzinga

Keep an eye on the top gainers and losers in Wednesday's session. ↗

July 01, 2026

Via Chartmill

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC

June 23, 2026

From Pomerantz LLP

Via GlobeNewswire

Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

June 23, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

June 23, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

REGENCELL DEADLINE JUNE 23rd: Bragar Eagel & Squire, P.C. Urgently Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role

June 22, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

June 22, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

June 20, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

REGENCELL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

June 18, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

REGENCELL DEADLINE TUESDAY JUNE 23rd: Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role

June 17, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC

June 16, 2026

From Pomerantz LLP

Via GlobeNewswire

RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

June 13, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role

June 12, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

REGENCELL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100Kto Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

June 12, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC

June 09, 2026

From Pomerantz LLP

Via GlobeNewswire

REGENCELL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

June 09, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role

June 04, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC

June 02, 2026

From Pomerantz LLP

Via GlobeNewswire

RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

June 02, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm Before June 23rd

May 29, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC

May 26, 2026

From Pomerantz LLP

Via GlobeNewswire

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

May 26, 2026

From Robbins LLP

Via Business Wire

Frequently Asked Questions

Is Regencell Bioscience Holdings Limited - Ordinary Shares publicly traded?

Yes, Regencell Bioscience Holdings Limited - Ordinary Shares is publicly traded.

What exchange does Regencell Bioscience Holdings Limited - Ordinary Shares trade on?

Regencell Bioscience Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares?

The ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares is RGC on the Nasdaq Stock Market

What is the current price of Regencell Bioscience Holdings Limited - Ordinary Shares?

The current price of Regencell Bioscience Holdings Limited - Ordinary Shares is 5.750

When was Regencell Bioscience Holdings Limited - Ordinary Shares last traded?

The last trade of Regencell Bioscience Holdings Limited - Ordinary Shares was at 08/05/26 12:36 PM ET

What is the market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares?

The market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares is 74.82M

How many shares of Regencell Bioscience Holdings Limited - Ordinary Shares are outstanding?

Regencell Bioscience Holdings Limited - Ordinary Shares has 75M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.